1. Home
  2. GABC vs NRIX Comparison

GABC vs NRIX Comparison

Compare GABC & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo German American Bancorp Inc.

GABC

German American Bancorp Inc.

HOLD

Current Price

$44.29

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo Nurix Therapeutics Inc.

NRIX

Nurix Therapeutics Inc.

HOLD

Current Price

$17.02

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GABC
NRIX
Founded
1910
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
GABC
NRIX
Price
$44.29
$17.02
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$46.50
$30.50
AVG Volume (30 Days)
127.0K
1.2M
Earning Date
04-27-2026
04-08-2026
Dividend Yield
2.81%
N/A
EPS Growth
8.13
N/A
EPS
3.06
N/A
Revenue
$487,401,000.00
$76,987,000.00
Revenue This Year
$16.89
N/A
Revenue Next Year
$3.94
$48.05
P/E Ratio
$14.42
N/A
Revenue Growth
37.80
99.31
52 Week Low
$35.04
$8.20
52 Week High
$45.00
$22.50

Technical Indicators

Market Signals
Indicator
GABC
NRIX
Relative Strength Index (RSI) 64.17 59.28
Support Level $37.47 $16.81
Resistance Level $44.77 $19.98
Average True Range (ATR) 0.79 0.91
MACD 0.11 0.20
Stochastic Oscillator 83.95 76.12

Price Performance

Historical Comparison
GABC
NRIX

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include the core banking segment and the wealth management segment. The core banking segment involves attracting deposits from the general public and using those funds to originate consumer, commercial, and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services, which involve providing trust, investment advisory, brokerage, and retirement planning services to customers. The company generates the majority of its revenue from the core banking segment.

About NRIX Nurix Therapeutics Inc.

Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.

Share on Social Networks: